
- Volume 0 0
AARP URGES SENIORS WITH PART D PROBLEMS TO SWITCH PHARMACIES
What are seniors todo if they encounter difficultiesfilling MedicarePart D prescriptions?According to AARP,they should considerswitching pharmacies.
Leaders of AARP have told membersthat they should go elsewhere if theyfind problems having Part D prescriptionsfilled.Chief Executive Officer (CEO)William D. Novelli characterized theinability of many retail pharmacies toverify eligibility for the new Rx benefit as"unacceptable." He said, "If individualsare having trouble at one pharmacy, weare recommending they try another."
NCPA, however, recognizes the troublesencountered at the initiation of theprogram but reflects on the advantagesand safety seniors realize by continuingto use their same pharmacist. BruceRoberts, RPh, executive vice presidentand CEO of NCPA, stated, "Unfortunately,for both patients and pharmacists,the normal experience at the pharmacyhas been disrupted during the launch ofMedicare Part D. Pharmacists arespending long hours working with theirpatients to ensure that they are walkingout of the pharmacy with the medicationsthey need. Not only is it dangerousto switch back and forth between pharmacies,[but] most independent communitypharmacies have long-term, personalrelationships with their patients,and that's something most patientsdon't want to sacrifice."
Articles in this issue
almost 20 years ago
British Poll Shows People Denying Weight Problemsalmost 20 years ago
Suing a Lawyer for Malpractice?almost 20 years ago
Pharmacists—Cops or Not? (Part 1)almost 20 years ago
Can You Read These Rxs?almost 20 years ago
Alternative Measures for Treating Pediculosisalmost 20 years ago
Compounding Hotlinealmost 20 years ago
Obesity May Lead to Kidney Failurealmost 20 years ago
Body Fat Associated with Alzheimer's Proteinalmost 20 years ago
Midlife Obesity May Cause Heart Diseasealmost 20 years ago
The Evolution of Imprint IdentificationNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.










































































































































































































